Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Concerning Is Pfizer and Opko's Latest FDA Rejection?

TheMotleyFool

0 0

How Concerning Is Pfizer and Opko's Latest FDA Rejection?

The U.S. Food and Drug Administration (FDA) recently refused to approve Pfizer's (NYSE: PFE) and Opko Health's (NASDAQ: OPK) growth hormone therapy, somatrogon. In this Motley Fool Live video, recorded on Jan. 26, Motley Fool contributors Keith Speights and Brian Orelli discuss how concerning this rejection is for the two companies.

Source Fool.com

Like: 0

PFE

Share